Completed PHASE3 INTERVENTIONAL NCT00781404

Myocardial Protection With Adenosine During Primary Percutaneous Coronary Intervention in Pts With STEMI (PROMISE)

Myocardial Protection During reperfusión in Patients With Acute Coronary Syndrome With ST Segment Elevation Submitted to Primary Angioplasty: Effect of Intracoronary Adenosine on Infarct Size and Ventricular Remodeling.

Sponsor: David Garcia-Dorado

Conditions Acute Myocardial Infarction

Interventions Adenosine

Updated 5 times since 2017 Last updated: Feb 15, 2013 Started: Oct 31, 2008 Primary completion: May 31, 2012 Completion: Jul 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Acute Myocardial Infarction and is currently completed. David Garcia-Dorado leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3
Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

Oct 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

David Garcia-Dorado
Hospital Clínico Universitario de Valladolid
Hospital General Universitario Gregorio Marañon
Hospital Universitario Virgen Macarena
Instituto de Ciencias del Corazon

Data source: Hospital Universitari Vall d'Hebron Research Institute

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Barcelona, Spain